Axsome Therapeutics (AXSM)

Axsome Therapeutics Australia Pty Ltd • Axsome Therapeutics, Limited • Axsome International Holdings LLC • Axsome Malta Holdings Ltd. • Axsome Malta Ltd. • Axsome Canada, Inc. ...

AXSM stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$155.20

Low target

$116.00

High target

$190.00

Latest filings (excl ownership)

View all

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue

13 Jan 25

8-K

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation

30 Dec 24

8-K

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy

12 Nov 24

Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

12 Nov 24

8-K

Entry into a Material Definitive Agreement

1 Oct 24

8-K

Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine

Registration of securities for employees

5 Aug 24

Transcripts

View all

AXSM

Earnings call transcript

2024 Q3

12 Nov 24

AXSM

Earnings call transcript

2024 Q2

5 Aug 24

AXSM

Earnings call transcript

2024 Q1

6 May 24

AXSM

Earnings call transcript

2023 Q4

20 Feb 24

AXSM

Earnings call transcript

2023 Q3

6 Nov 23

AXSM

Earnings call transcript

2023 Q2

7 Aug 23

AXSM

Earnings call transcript

2023 Q2

7 Aug 23

AXSM

Earnings call transcript

2023 Q1

8 May 23

AXSM

Earnings call transcript

2022 Q4

27 Feb 23

AXSM

Earnings call transcript

2022 Q3

7 Nov 22

Latest ownership filings

View all

Notice of proposed sale of securities

Notice of proposed sale of securities

Financial summary

Financial statements Chart AXSM financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	327.34 mm	327.34 mm	327.34 mm	327.34 mm	327.34 mm	327.34 mm
Cash burn (monthly)	(no burn)	7.44 mm	21.53 mm	25.94 mm	6.21 mm	11.05 mm
Cash used (since last report)	n/a	32.56 mm	94.30 mm	113.60 mm	27.20 mm	48.38 mm
Cash remaining	n/a	294.78 mm	233.04 mm	213.75 mm	300.14 mm	278.96 mm
Runway (months of cash)	n/a	39.6	10.8	8.2	48.3	25.3

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

AXSM institutional ownership history Ownership history

79.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	278	255	+9.0%
Opened positions	48	38	+26.3%
Closed positions	25	32	-21.9%
Increased positions	82	73	+12.3%
Reduced positions	92	96	-4.2%

13F shares	Current	Prev Q	Change
Total value	3.38 tn	3.24 tn	+4.3%
Total shares	38.28 mm	40.73 mm	-6.0%
Total puts	854.90 k	427.60 k	+99.9%
Total calls	910.90 k	363.60 k	+150.5%
Total put/call ratio	0.9	1.2	-20.2%

Largest owners	Shares	Value	Change
RTW Investments	4.19 mm	$376.52 bn	-9.6%
Vanguard	4.00 mm	$359.06 bn	+6.8%
BlackRock	3.40 mm	$305.41 bn	NEW
Fairmount Funds Management	2.36 mm	$212.10 bn	0.0%
FMR	1.09 mm	$97.79 bn	+20.6%
BVF	1.05 mm	$94.00 bn	+9.5%
Ra Capital Management	1.00 mm	$89.87 bn	0.0%
MQBKY Macquarie Group Limited	995.29 k	$89.45 bn	-7.3%
STT State Street	916.81 k	$82.39 bn	-2.3%
Geode Capital Management	908.46 k	$81.66 bn	+2.7%

Largest transactions	Shares	Bought/sold	Change
BlackRock	3.40 mm	+3.40 mm	NEW
BLK BlackRock	0.00	-3.30 mm	EXIT
Deep Track Capital	857.22 k	-995.57 k	-53.7%
Millennium Management	24.75 k	-715.07 k	-96.7%
Citadel Advisors	304.68 k	-448.56 k	-59.6%
RTW Investments	4.19 mm	-444.77 k	-9.6%
Norges Bank	0.00	-404.22 k	EXIT
Perceptive Advisors	782.84 k	+323.73 k	+70.5%
Vestal Point Capital	0.00	-300.00 k	EXIT
Vanguard	4.00 mm	+253.34 k	+6.8%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

AXSM insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
3 Jan 25	Coleman Mark	Common Stock	Option exercise	Acquire M	No	No	9	9,127	82.14 k	57,137
3 Jan 25	Coleman Mark	Stock Option Common Stock	Option exercise	Dispose M	No	No	9	9,127	82.14 k	0
19 Nov 24	Coleman Mark	Common Stock	Option exercise	Acquire M	No	No	5.94	33,410	198.46 k	48,010
19 Nov 24	Coleman Mark	Stock Option Common Stock	Option exercise	Dispose M	No	No	5.94	33,410	198.46 k	0
11 Sep 24	Saad Mark E	Common Stock	Sell	Dispose S	No	No	91.31	11,016	1.01 mm	10,002
11 Sep 24	Saad Mark E	Common Stock	Option exercise	Acquire M	No	No	3.67	11,016	40.43 k	21,018
11 Sep 24	Saad Mark E	Stock Option Common Stock	Option exercise	Dispose M	No	No	3.67	11,016	40.43 k	0
9 Aug 24	Mark L. Jacobson	Common Stock	Sell	Dispose S	No	No	84.26	47,739	4.02 mm	5,783
9 Aug 24	Mark L. Jacobson	Common Stock	Option exercise	Acquire M	No	No	4.04	47,739	192.87 k	53,522
9 Aug 24	Mark L. Jacobson	Stock Option Common Stock	Option exercise	Dispose M	No	No	4.04	47,739	192.87 k	0